Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
18(5):415-420
2109424-53-3 (SAG(trans-cis) HCl)
is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist extracted from patent WO2018146010A1
5-trimethyl-3
In LAPC-4 cells
GNE-317 O1138452 18(5):415-420GNE 317 is a potent and selective PI3K inhibitor with potential anticncer activity. GNE 317 targets the PI3K pathway and can cross the BloodBrain Barrier. GNE 317 was identified as having physicochemical properties predictive of low efflux by P gp and BCRP. Studies in transfected MDCK cells showed that GNE 317 was not a substrate of either transporter. GNE 317 markedly inhibited the PI3K pathway in mouse brain, causing 40% to 90% suppression of the
US$ 85.00
US$ 68.00
US$ 100.00
US$ 125.00
US$ 89.00
US$ 85.00
US$ 65.00
US$ 36.00
US$ 38.00
US$ 74.00
US$ 125.00
US$ 65.00